Updated on 14 October 2026
Looking for co-investment in seed stage in the area of quantitative POCT diagnostics for human and veterinary health
Owner of CSICC and CIO of CENIOS GmbH at CSICC - Carmona-Schneider International Cooperation Consulting and CENIOS GmbH
Bochum, Germany
About
CENIOS is a deep-tech start-up specialising in nanodiagnostics and rapid, quantitative point-of-care tests (POCT).
What we do:
-
Detect analytes such as cytostatics, antibiotics, toxins, and pesticides
-
Develop applications for human and veterinary medicine, food safety, and environmental analysis
-
Provide faster and more affordable tests than existing solutions
-
Develop a dedicated reader for on-site testing
Our patented technology delivers fast, reliable, quantitative results at the point of need. It supports healthcare professionals, laboratories, and other users in making informed decisions and providing personalised treatment. Applications include the detection of toxins, anti-cytostatics, and antibiotic residues, as well as food-safety testing for dairy and meat products.
We are seeking seed investment to launch production, complete certification, drive marketing, and establish a broad distribution network.
Stage
- Seed and Development
- Growth and Establishment
Applies to
- LIFE SCIENCE
- MEDICINE
Organisation
CSICC - Carmona-Schneider International Cooperation Consulting and CENIOS GmbH
Consulting (business, tax, legal)
Bochum, Germany
Similar opportunities
Service
Spencer Parent
Technical Sales Engineer at Healtis | MRI Safety Assessment For Medical Devices
Vancouver, Canada
Product
- Buyer
- LIFE SCIENCE
- GENOME RESEARCH
- INDUSTRIAL BIOTECHNOLOGY
Tony Chung
President at Instant NanoBiosensors B.V.
Utrecht, Netherlands